Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies

NCT04537832 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2023-06-12

No results posted yet for this study

Summary

This is a multicenter, prospective, 2-year observational study in infants and children with developmental and epileptic encephalopathies (DEEs). The DEE currently being investigated is SCN1A-positive Dravet Syndrome.

Conditions

Interventions

OTHER

No Intervention

No Intervention

Sponsors & Collaborators

  • Encoded Therapeutics

    lead INDUSTRY

Principal Investigators

  • Salvador Rico, M.D., Ph.D · Encoded Therapeutics

Eligibility

Min Age
6 Months
Max Age
60 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-18
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • United States
  • Australia
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04537832 on ClinicalTrials.gov